STAT+: Psilocybin data could be good enough for approval
And other biotech news brought to you by The Readout newsletter
And other biotech news brought to you by The Readout newsletter
Ireland: Circulating fibrocytes may offer a promising new biomarker for diagnosing acute appendicitis, with diagnostic performance comparable to routinely used blood tests, a prospective study conducted at University Hospital Limerick,…
Brazil: The combination of periapical radiography (PR) and cone-beam computed tomography (CBCT) significantly improves diagnostic accuracy for both endodontists and periodontists. This integrated approach provides more reliable detection and assessment…
The FDA rejected a Disc Medicine therapy for a rare blood disorder, the first experimental drug to go through a new program to fast-track drug reviews
Ocular now plans to apply for FDA approval, but whether doctors and insurers will favor its new drug is an open question.
A recent nationwide study published in The National Medical Journal of India reveals that a significant portion (10.3% in the past year) of school-going adolescents in India engage in psychoactive…
Following an RTI response from the National Medical Commission (NMC), which revealed that it had rejected 256 appeals filed by non-RMPs but heard 185 appeals by doctors against decisions of…
A gynaecologist's body has urged the National Medical Commission (NMC), its Postgraduate Medical Education Board (PGMEB), to immediately review the decision to lower the qualifying percentile of NEET PG 2025.The…
Mumbai: 180 super-speciality doctors working in Mumbai’s municipal peripheral hospitals have gone without a single salary increment for five years. Appointed as DNB Teachers’ Grade 1 and 2, they have…
COMP360 could be the first psilocybin-based medicine to win approval.